Glycosylated hemoglobin
Hemoglobin to which glucose is bound. Glycosylated hemoglobin is tested to monitor the long-term control of diabetes mellitus.
The level of glycosylated hemoglobin is increased in the red blood cells of persons with poorly controlled diabetes mellitus. Since the glucose stays attached to hemoglobin for the life of the red blood cell (normally about 120 days), the level of glycosylated hemoglobin reflects the average blood glucose level over the past 3 months.
The normal level for glycosylated hemoglobin is less than 7%. Diabetics rarely achieve such levels, but tight control aims to come close to it. Levels above 9% show poor control, and levels above 12% show very poor control. It is commonly recommended that glycosylated hemoglobin be measured every 3 to 6 months in diabetes.
The Diabetes Control and Complications Trial (DCCT) showed that diabetics who keep their glycosylated hemoglobin levels close to 7% have a much better chance of delaying or preventing diabetes complications that affect the eyes, kidneys, and nerves than people with levels 8% or higher. A change in treatment is almost always needed if the level is over 8%. Lowering the level of glycosylated hemoglobin by any amount improves a person’s chances of staying healthy.
Glycosylated hemoglobin is also known as glycohemoglobin or as hemoglobin A1C (the main fraction of glycosylated hemoglobin).
Read Also:
- gm (gram)
The abbreviation gm stands for gram, a unit of measurement of weight and mass in the metric system. In weight, a gram is equal to a thousandth of a kilogram. In mass, a gram is equal to a thousandth of a liter (one cubic centimeter) of water at 4 degrees centigrade. The word “gram” comes […]
- GM1 gangliosidosis
A genetic lipid storage disorder that is similar in certain respects to Hurler syndrome and Tay-Sachs disease but which affects both the brain and the viscera (the internal organs). GM1 gangliosidosis causes skeletal deformities and exerts severe effects on the brain and internal organs. Death usually occurs by the age of 2. GM1 gangliosidosis is […]
- GM2-gangliosidosis, B variant
This disorder known as Tay-Sachs disease (TSD) is concisely defined by OMIM (Online Mendelian Inheritance in Man) as “an autosomal recessive, progressive neurodegenerative disorder, which in the classic infantile form, is usually fatal by age 2 or 3 years, results from deficiency of the enzyme hexosaminidase A. ” “Autosomal” points to the gene for TSD […]
- GM2-gangliosidosis, type 1
This disorder known as Tay-Sachs disease (TSD) is concisely defined by OMIM (Online Mendelian Inheritance in Man) as “an autosomal recessive, progressive neurodegenerative disorder, which in the classic infantile form, is usually fatal by age 2 or 3 years, results from deficiency of the enzyme hexosaminidase A. ” “Autosomal” points to the gene for TSD […]
- Gnashing
Grinding the teeth. More formally called “bruxism.” Gnashing, or bruxism, is due to clenching of the teeth other than in chewing and is associated with forceful lateral or protrusive jaw movements. This results in grinding or rubbing the teeth together. Gnashing usually occurs during sleep. It is sometimes so excessive that it damages the occlusal […]